This phase III trial compares BBT-CI to HEAL for the reduction of insomnia in patients with
stage I-III cancer who are receiving chemotherapy. Chemotherapy can cause side effects such
as sleep problems. Sleep problems such as insomnia, are common for cancer patients. Insomnia
can be described as difficulty falling asleep, waking up many times during the night or
waking up earlier than patient would like. Insomnia can increase fatigue and worsen quality
of life. This trial may help researchers determine which treatment works better in reducing
insomnia, BBT-CI or HEAL.
Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm